NAT10 Promotes Melanoma Progression by Driving SLC27A1-Dependent Lipid Metabolic Reprogramming
Researchers have revealed that NAT10 stabilizes JunB via lysine 343 acetylation to activate SLC27A1 transcription, driving lipid metabolic reprogramming and ...

